Myomo, Inc
(NYSE MKT:MYO)

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paral...

Website: http://www.myomo.com

Founded: 2009

IPO Price: $7.50 (Jun 12, 2017)

Full Time Employees: 49

Sector: Healthcare

Industry: Medical Devices

Healthcare Medical Devices

Share this website to your friends

• Market Cap:

• Exchange:

• Shs Outstanding:

• Employees:

• Beta:

• Return on Equity (ROE) ttm:

• Return on Assets (ROA) ttm:

• EPS ttm:

• Book value per Share:

• Cash per Share:

• Current ast per Share:

• P/E ttm:

• P/E forward:

• P/E ttm high:

• P/E ttm low:

• P/S ttm:

• P/B ttm:

• P/FCF ttm:

• PEG ratio:

• Cash Ratio ttm:

• Quick Ratio ttm:

• Current Ratio ttm:

• Gross Mgn ttm:

• EBITDA Mgn ttm:

• Operating Mgn ttm:

• Net Income Mgn ttm:

• Trailing Div yield:

• Forward Div yield:

• Payout Ratio ttm:

• Ex-Dividend date:

• Target Price High:

• Target Price Low:

• Target Price Mean:

• Number of Analysts:

• Debt Ratio ttm:

• Debt to Equity ttm:

• Total Net Debt:

At a glance:

Bull Thesis:

Bear Thesis:

Main Competitors:

Moat:

Income Statements:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30

revenue	10,113,288	11,353,296	10,090,699	9,652,234														4,031,634	4,383,957	3,104,294	2,336,489	3,789,976	1,926,660	858,590	1,008,145	1,520,696	606,619	880,349	830,066	889,575	608,981	632,369	313,179	547,412	488,540	306,683
yoy																		6.38%	127.54%	261.56%	131.76%	149.23%	217.61%	-2.47%	21.45%	70.95%	-0.39%	39.21%	165.05%	62.51%	24.65%	106.20%
qoq	-10.92%	12.51%	4.54%															-8.04%	41.22%	32.86%	-38.35%	96.71%	124.40%	-14.83%	-33.71%	150.68%	-31.09%	6.06%	-6.69%	46.08%	-3.70%	101.92%	-42.79%	12.05%	59.30%
cost of revenue	3,211,682	3,569,022	3,648,451	3,600,061	3,222,184	3,453,224	2,262,031	2,195,255	1,455,345	1,651,506	1,590,675	1,677,488	1,139,074	1,413,916	1,331,217	1,266,938	1,289,862	909,175	1,110,204	901,566	623,152	1,007,524	855,338	418,862	318,651	296,386	194,375	250,676	176,187	226,176	193,577	200,446	108,080	203,972	124,098	98,641
gross profit	6,901,606	7,784,274	6,442,248	6,052,173	6,609,630	8,615,233	6,945,555	5,325,512	2,299,044	3,104,878	3,488,848	4,281,056	2,307,634	2,627,611	2,636,984	2,410,637	2,578,064								689,494
yoy	4.42%	-9.65%	-7.25%	13.64%	187.49%	177.47%	99.08%	24.40%	-0.37%	18.16%	32.30%	77.59%	-10.49%
qoq	-11.34%	20.83%	6.45%	-8.43%	-23.28%	24.04%	30.42%	131.64%	-25.95%	-11.01%	-18.50%	85.52%	-12.18%	-0.36%	9.39%	-6.49%
gross margin %	68.24%	68.56%	63.84%	62.70%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	0%	0%	0%	0%	0%	0%	0%	68.39%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
operating expenses:
research and development	1,623,160	1,624,823	1,527,660	2,001,331	1,790,024	1,559,704	1,248,870	1,007,224	956,215	878,006	717,256	564,235	476,991	499,674	690,407	632,872	659,536	787,628	641,228	600,116	525,967	418,758	345,666	397,811	506,953	544,757	544,679	535,898	535,254	529,619	449,673	486,982	372,359	356,866	329,357	708,622
selling, clinical and marketing	4,816,759	3,720,984	5,254,246	5,233,885	4,395,804	2,135,040.25	3,401,182	2,777,135	2,361,845
general and administrative	3,618,739	3,432,047	3,177,856	3,407,277	3,944,056	3,604,094	3,253,056	2,656,217	2,869,751
operating expenses: - sum	10,058,658	10,558,032	9,959,762	10,642,493	10,129,884	8,860,547	7,903,108	6,440,576	6,187,811	5,538,055	5,513,217	5,384,062	4,978,599	4,856,962	5,455,625	5,296,960	5,315,953	5,828,190	5,304,024	4,802,360	4,645,769	4,469,063	3,616,423	3,288,275	4,111,921	3,805,126	3,237,292	3,336,017	3,336,674	3,398,426	3,123,833	3,113,987	2,607,996			2,141,484
income from operations	-3,157,052	-2,773,758	-3,517,514	-4,590,320	-3,520,254	-245,314	-957,553	-1,115,064	-3,888,767	-2,433,177	-2,024,369	-1,103,006	-2,670,965	-2,229,351	-2,818,641	-2,886,323	-2,737,889	-2,705,731	-2,030,271	-2,599,632	-2,932,432	-1,686,611	-2,545,101	-2,848,547	-3,422,427	-2,580,816	-2,825,048	-2,706,344	-2,682,795	-2,735,027	-2,708,429	-2,682,064	-2,402,897	-1,816,010	-1,434,973	-1,933,442
yoy	-10.32%	1030.70%	267.34%	311.66%	-9.48%	-89.92%	-52.70%	1.09%	45.59%	9.14%	-28.18%	-61.79%	-2.44%	-17.61%	38.83%	11.03%	-6.63%	60.42%	-20.23%	-8.74%	-14.32%	-34.65%	-9.91%	5.25%	27.57%	-5.64%	4.31%	0.91%	11.65%	50.61%	88.74%	38.72%
qoq	13.82%	-21.14%	-23.37%	30.40%	1335.00%	-74.38%	-14.13%	-71.33%	59.82%	20.19%	83.53%	-58.70%	19.81%	-20.91%	-2.34%	5.42%	1.19%	33.27%	-21.90%	-11.35%	73.87%	-33.73%	-10.65%	-16.77%	32.61%	-8.65%	4.39%	0.88%	-1.91%	0.98%	0.98%	11.62%	32.32%	26.55%	-25.78%
operating margin %	-31.22%	-24.43%	-34.86%	-47.56%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-67.11%	-46.31%	-83.74%	-125.51%	-44.50%	-132.10%	-331.77%	-339.48%	-169.71%	-465.70%	-307.42%	-323.20%	-307.45%	-444.75%	-424.13%	-767.26%	-331.74%	-293.73%	-630.44%
other expense										-5,313	467	5,631	31
interest expense	504,696	739,629	9,743
change in fair value of derivative liabilities	-839,064																						-888	-39,717	-82,101	-38,530	-14,536	-99,449	-41,970	-4,991	-13,310	-2,661	-15,307	-52,429	-219,374	130,162
income before income taxes	-2,822,684	-3,730,060	-3,527,257	-4,483,771	-3,328,263	-175,283	-881,533	-1,007,822	-3,753,474	-2,389,307	-1,982,660	-1,017,712	-2,601,884	-2,190,715	-2,806,334	-2,915,357	-2,738,679	-2,710,874	-2,034,326	-2,605,650	-2,932,551	-2,465,661.75	-2,775,418	-3,285,849	-3,801,380
income tax expense	186,715	83,878	135,658	148,201	136,795	84,798	84,876	113,785	82,158	70,798	46,355	-3,562	42,411	-23,265	23,382	-6,435	76,255	22,324	22,696	15,665	28,243	712.75	1,153	1,085	613
net income	-3,009,399	-3,813,938	-3,662,915	-4,631,972	-3,465,058	-260,081	-966,409	-1,121,607	-3,835,632	-2,460,104	-2,029,016	-1,014,150	-2,644,295	-2,167,450	-2,829,716	-2,908,922	-2,814,934	-2,733,198	-2,057,022	-2,621,315	-2,960,794	-1,698,413	-2,776,571	-3,286,934	-3,801,993	-2,761,504	-2,788,118	-2,565,327	-2,598,060	-2,691,954	-2,649,822	-2,629,561	-2,345,402	-1,900,276	-1,258,949	-7,381,854
yoy	-13.15%	1366.44%	279.02%	312.98%	-9.66%	-89.43%	-52.37%	10.60%	45.05%	13.50%	-28.30%	-65.14%	-6.06%	-20.70%	37.56%	10.97%	-4.93%	60.93%	-25.92%	-20.25%	-22.13%	-38.50%	-0.41%	28.13%	46.34%	2.58%	5.22%	-2.44%	10.77%	41.66%	110.48%	-64.38%
qoq	-21.09%	4.12%	-20.92%	33.68%	1232.30%	-73.09%	-13.84%	-70.76%	55.91%	21.25%	100.07%	-61.65%	22.00%	-23.40%	-2.72%	3.34%	2.99%	32.87%	-21.53%	-11.47%	74.33%	-38.83%	-15.53%	-13.55%	37.68%	-0.95%	8.68%	-1.26%	-3.49%	1.59%	0.77%	12.12%	23.42%	50.94%	-82.95%
net income margin %	-29.76%	-33.59%	-36.30%	-47.99%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-67.79%	-46.92%	-84.44%	-126.72%	-44.81%	-144.11%	-382.83%	-377.13%	-181.59%	-459.62%	-291.40%	-312.99%	-302.61%	-435.12%	-415.83%	-748.90%	-347.14%	-257.70%	-2407.00%
weighted-average number of common shares outstanding:
basic and diluted	42,269,133	41,855,607	42,168,120	41,582,737	41,454,472	37,758,837	37,950,515	37,368,488	36,752,597	29,499,341	35,266,361	27,992,928	24,196,732	7,051,447	7,064,188	6,923,799	6,885,924	5,830,353	5,681,121	5,639,524	5,191,417	3,329,868	3,940,113	2,932,570	1,778,708	553,782	17,158,731	17,105,527	14,941,518	12,292,402	12,415,494	12,407,758	11,899,456	4,317,864	6,081,195	2,312,649
net income per share
basic and diluted	-0.07	-0.09	-0.09	-0.11	-0.08		-0.03	-0.03	-0.1	-0.07	-0.06	-0.04	-0.11	-0.28	-0.4	-0.42	-0.41	-0.51	-0.36	-0.46	-0.57	-0.04	-0.7	-1.12	-2.51	-18.87	-0.16	-0.15	-0.17	-0.22	-0.21	-0.21	-0.2	0.44	-0.21	-3.35
other (income)
interest (income)				-106,549
product revenue					9,831,814	12,068,457	9,207,586	7,520,767	3,754,389	4,756,383	5,029,523	4,243,624	3,446,708	4,041,527	3,968,201	3,677,575	2,867,926
interest income					-191,991	-70,031	-76,020	-107,242	-135,293	-108,221	-112,300	-103,439	-86,314
license revenue											50,000	1,714,920					1,000,000
revenue - sum						12,068,457	9,207,586	7,520,767		4,756,383	5,079,523	5,958,544	3,446,708	4,041,527	3,968,201	3,677,575	3,867,926
loss on equity investment										69,663	70,124	12,514	17,202	16,651	16,652
selling, general and administrative										4,660,048	4,795,961	4,819,827	4,501,608	4,357,288	4,765,218	4,664,088	4,656,417	5,040,562	4,662,796	4,202,244	4,119,802	4,050,305	3,270,757	2,890,464	3,604,968	3,260,369	2,692,613	2,800,119	2,801,420	2,868,807	2,674,160	2,627,005	2,235,637	1,802,584	1,470,058	1,432,862
other expense, including interest income														-8,085.75	-28,959	-4,174	790
other expense - sum														-38,636	-12,307	29,034	790	5,143	4,055	6,018	119	14,653	230,317	437,302	378,953	180,688	-36,930	-141,017	-84,735	-43,073	-58,607	-52,503	-57,495			5,448,412
loss on investment in minority interest																33,208
gross margin																		1,797,454.5	3,273,753	2,202,728	1,713,337	550,136	1,071,322	439,728		423,949.25	412,244	629,673	653,879	663,399	415,404	431,923	205,099	343,440	364,442	208,042
interest income and other expense																		2,548.25	4,055	6,018	119	63,509.75	29,915	88,915				-41,568	-42,765	-34,331.75	-45,297	-49,842	-42,188
non-cash interest expense, debt discount																							12,135	40,025	166,643
loss on extinguishment of debt																						174,109	189,155	348,079	159,202
deemed dividend on repricing of warrants																									670,632
net loss attributable to common stockholders																		-3,373,151	-2,057,022	-2,621,315	-2,960,794	-1,698,413	-2,776,571	-3,286,934	-4,472,625
interest expense and other expense																									135,209
interest (income) and other expense																										105,587	-22,394
debt discount on convertible notes
deemed dividend – accreted preferred stock
cumulative dividend to series b-1 preferred stockholders																																				-125,903
net loss available to common stockholders																														-2,691,954	-2,649,822	-2,629,561	-2,345,402	-1,900,276	-1,258,949	-7,754,584
total operating expenses																																		1,360,562.5	1,799,415
interest and other expense																																		1,451	43,350	146,250
total other expense																																		1,366,274.75	-176,024
deemed discount – accreted preferred stock discount																																		-68,502.75		-246,827
debt discount or convertible notes																																				5,172,000

Balance Sheets:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30

assets
current assets:
cash and cash equivalents	11,396,426	14,132,027	12,553,558	14,240,432	19,793,799	24,372,373	6,622,675	5,846,100	5,434,726	6,871,306	6,911,747	6,006,283	9,263,560	5,345,967	7,420,020	10,235,914	12,942,507	15,524,378	12,606,758	13,772,464	17,371,217	12,241,261	13,317,581	10,733,419	13,726,482	4,465,455	4,328,355	6,668,871	9,233,559	6,540,794	9,093,412	11,683,729	14,116,430	12,959,373
short-term investments	4,299,978	4,261,782		1,241,515	1,730,460	492,990		3,135,801	5,523,664	1,994,662	4,208,613	2,950,268
accounts receivable	4,824,537	4,096,327	5,292,520	7,054,545	4,663,398	3,825,291	3,729,387	2,526,361	1,683,414	2,382,658	2,517,021	1,641,803	1,547,801	1,896,163	1,595,266	1,357,477	1,692,573	1,960,037	2,215,696	1,132,078	765,226	924,916	308,523	310,517	299,287	424,287	134,006	331,013	399,895	382,258	352,824	384,951	151,445	297,039	225,934	254,031
inventories	3,548,424	3,123,089	3,645,314	4,125,597	3,368,502	3,165,965	3,383,513	2,601,104	2,386,497	1,803,507	1,484,729	1,337,353	1,565,268	1,399,865	1,482,935	1,260,936	1,028,767	808,308	644,138	728,638	793,791	707,114	759,803	678,906	602,881	439,533	454,379	349,196	301,277	256,149	272,664	247,624	237,879	201,155	123,351	123,028
prepaid expenses and other current assets	1,588,453	1,943,860	1,457,595	1,381,721	1,541,118	933,377	968,569	1,032,323	676,787	598,850	920,076	694,641	535,558	573,462	553,696	451,100	940,929	894,494	994,137						937,218		786,732
total current assets	25,657,818	27,557,085	22,948,987	28,043,810	31,097,277	32,789,996	14,704,144	15,141,689	15,705,088	13,650,983	16,042,186	12,630,348	12,912,187	9,215,457	11,051,917	13,305,427	16,604,776	19,187,217	16,460,729	16,632,207	19,928,997	14,445,975	15,176,197	12,643,225	15,565,868	6,149,481	5,703,472	8,166,558	10,719,451	7,874,477	10,439,766	12,779,086	14,878,847	13,845,842	5,773,253	7,761,270
restricted cash	575,000	575,000	375,000	375,000	375,000	375,000	375,000																75,000	75,000	75,000	75,000	75,000	75,000	75,000	75,000	75,000	75,000	52,000	52,000	52,000	52,000
operating lease assets with right of use	6,499,282		6,870,283	7,058,063	7,295,711		466,962	539,498	604,897		715,876	299,118	406,915		604,960	695,933	781,917		696,345
equipment	2,242,811	2,212,901	3,714,810	2,908,804	1,842,254	1,330,008	561,325	289,303	205,917	175,794	172,018	153,719	190,736	194,283	239,955	283,317	279,538	275,289	302,110	320,238	210,296	95,023	105,589	109,880	139,205	154,972	170,330	192,574	173,078	187,513	198,865	163,849	155,319	77,150	21,822	22,004
software development costs	1,757,402	1,590,864
other assets	21,374	21,374	168,350	286,670	257,085	164,412	205,440	219,891	4,955	91,237	91,237	111,034	111,034	111,034	111,034	111,034	111,409
total assets	36,753,687	38,636,573	34,077,430	38,672,347	40,867,327	42,244,079	16,312,871	16,190,381	16,520,857	14,581,568	17,053,965	13,296,992	13,736,159	10,162,006	12,157,006	14,561,503	17,976,640	20,095,412	17,459,184	17,708,666	20,923,109	14,709,782	15,356,786	12,828,105	15,912,049	6,598,693	6,082,778	8,542,534	11,099,505	8,281,572	10,830,904	13,066,977	15,086,166	13,974,992	5,958,794	7,835,274
liabilities and stockholders’ equity
current liabilities:
accounts payable and accrued expenses	7,020,809	5,819,767	6,668,162	8,313,862	10,448,565	9,021,817	6,448,076	5,868,407	4,963,707	4,885,944	5,225,320	3,977,460	3,475,543	3,179,362	3,649,085	3,445,339	4,240,213	3,949,784	3,420,654	2,899,948	3,892,475	2,848,904	2,122,140	1,689,031	2,628,328	1,738,450
current operating lease liability	594,937	494,662	464,239	460,351	765,616	748,021	205,464	316,600	421,514	486,143	456,064	181,783	275,028	353,701	441,386	436,694	410,497	333,380	301,878	319,624	204,460	18,289
taxes payable	863,236	813,260
deferred revenue	187,498	218,222	134,750	108,780	129,852	83,115	31,971	12,015		8,510	30,685	747	747	20,653	23,053	2,211	1,899	249	1,495			2,512	6,684	1,495	4,131	2,913	2,942	570	25,840	1,990	182,515	149,086	142,129	168,006	68,958	81,560
warrant derivative liability	718,540	999,418
total current liabilities	9,385,020	8,345,329	9,202,458	11,753,770	11,675,269	10,171,838	6,991,372	6,465,332	5,556,501	5,477,058	5,777,645	4,337,177	3,934,086	3,601,936	4,113,524	3,884,244	4,652,609	4,283,413	3,722,532	3,219,572	4,096,935	2,869,705	2,206,869	2,688,255	4,127,797	3,883,529	1,662,758	1,435,965	1,578,313	1,855,687	1,881,720	1,570,383	1,116,598	1,485,172	1,893,221	1,981,898
non-current operating lease liability	7,440,778		7,832,722	7,970,116	7,504,994		29,165	47,338	64,599	115,160	253,210	139,657	169,770	200,207	220,901	328,729	453,073	401,622	474,188	562,887	644,107	155,148
long-term debt	10,926,208	11,222,155	2,416,667	1,333,333																						888,961
total liabilities	27,752,006	27,233,106	19,451,847	21,057,219	19,180,263	17,530,022	7,020,537	6,512,670	5,621,100	5,592,218	6,030,855	4,476,960	4,104,168	3,802,641	4,335,110	4,213,907	5,106,928	4,686,281	4,311,638	3,897,377	4,855,960	3,144,408	2,374,253	2,774,847	4,129,292	4,773,985	1,664,253	1,435,965	1,578,313	1,855,687	1,881,969	1,615,879	1,162,094	1,529,214	3,383,409	3,912,716
commitments and contingencies
stockholders’ equity:
preferred stock, 0.0001 par value...
common stock par value 0.0001...	3,856	3,847	3,843	3,778	3,446	3,439	3,026	3,021	2,881	2,715	2,652	2,110	2,092	775	706	698	688	687	584	570	560	457	456	322		57	1,716	1,713		1,245	1,243	1,241	1,240	1,114	611	604
additional paid-in capital	130,527,228	129,929,989	129,365,034	128,781,048	128,386,223	127,846,026	111,754,495	111,430,314	111,522,270	105,840,239	105,506,182	101,226,783	100,954,887	95,105,071	94,454,914	94,149,289	93,804,076	93,537,807	88,492,959	87,091,409	86,728,107	79,273,964	78,980,021	73,274,309	71,716,915	57,957,097	57,787,751	57,687,680	57,536,979	51,720,630	51,551,728	51,404,071	51,247,485	47,423,915	35,653,749	35,741,980
accumulated other comprehensive income	174,882	164,517	137,653	48,334		-14,406	395,734	138,888	147,511	83,669	-8,554	39,292	109,015	43,227
accumulated deficit	-121,697,821	-118,688,422	-114,874,483	-111,211,568	-106,579,596	-103,114,538	-102,854,457	-101,888,048	-100,766,441	-96,930,809	-94,470,705	-92,441,689	-91,427,539	-88,783,244	-86,615,794	-83,786,078	-80,877,156	-78,062,222	-75,329,024	-73,272,002	-70,650,687	-67,689,893	-65,991,480	-63,214,909	-59,927,975	-56,125,982	-53,364,478	-50,576,360	-48,011,033	-45,289,526	-42,597,572	-39,947,750	-37,318,189	-34,972,787	-33,072,511	-31,813,562
treasury stock	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464	-6,464
total stockholders’ equity	9,001,681	11,403,467	14,625,583	17,615,128	21,687,064	24,714,057	9,292,334	9,677,711	10,899,757	8,989,350	11,023,111	8,820,032	9,631,991	6,359,365	7,821,896	10,347,596	12,869,712	15,409,131	13,147,546	13,811,289	16,067,149	11,565,374	12,982,533	10,053,258	11,782,757	1,824,708	4,418,525	7,106,569	9,521,192	6,425,885	8,948,935	11,451,098	13,924,072	12,445,778
total liabilities and stockholders’ equity	36,753,687	38,636,573	34,077,430	38,672,347	40,867,327	42,244,079	16,312,871	16,190,381	16,520,857	14,581,568	17,053,965	13,296,992	13,736,159	10,162,006	12,157,006	14,561,503	17,976,640	20,095,412	17,459,184	17,708,666	20,923,109	14,709,782	15,356,786	12,828,105	15,912,049	6,598,693	6,082,778	8,542,534	11,099,505	8,281,572	10,830,904	13,066,977	15,086,166
operating lease assets with right-of-use		6,679,349				7,584,663				663,554				508,743				632,906		756,221	783,816	168,784
non-current operating lease liability, net of current portion		7,665,622				7,358,184
commitments and contingencies - note 12
income taxes payable			351,974	204,110	331,236	318,885	305,861	268,310	171,280	96,461	65,576	177,187	182,768	48,220
current portion long-term debt			583,333	166,667
revolving credit line			1,000,000	2,500,000
accumulated other comprehensive loss					-116,545										-11,466	-9,849	-51,432	-60,677	-10,509	-2,224	-4,367	-12,690
commitments and contingencies - note 10
investment in jiangxi myomo medical assistive appliance co. ltd.												102,773	115,287	132,489	149,140	165,792	199,000
investment in jiangxi myomo medical assistive appliance co., ltd.											32,648
deferred revenue, net of current portion												126	312		685	934															249	45,496	45,496	44,042
commitments and contingencies - note 9
other long-term liabilities																			113,423	113,423	113,423	118,060	165,889
prepaid expenses and other																				999,027	998,763	572,684	790,290	920,383		820,206		817,478	784,720	695,276	720,866	462,782	373,093	388,275	465,880	273,970
deferred offering costs																									131,976	219,240	133,976	108,402	131,976	144,582	117,273	49,042			111,719
current portion of long-term debt, net of discount of 676,703 at december 31, 2019																										1,763,887
derivative liabilities																								888	40,605	378,239	43,942	58,477	157,927	3,661	8,652	21,962	24,623	39,930	92,359	311,733
convertible note payable, net of discount of 553 and 676,703 at september 30, 2020 and december 31, 2019, respectively																							78,045
convertible note payable, net of discount of 71,360 and 676,703 at june 30, 2020 and december 31, 2019, respectively																								996,841
other long-term debt liabilities																								77,892
current portion of long-term debt, net of discount of 298,542 and 676,703 at march 31 2020 and december 31, 2019, respectively																									1,427,393
customer advance payments																									27,340	40	63,567	40	84,117	106,609
common stock, par value 0.0001...																									281
accounts payable and other accrued expenses																											1,552,307	1,376,878	1,310,429	1,743,427	1,690,553	1,399,335	949,846	1,277,236	1,130,232	1,308,349
non-current liabilities																											1,495
common stock																													1,710
undesignated preferred stock par value 0.0001...
liabilities, redeemable and convertible preferred stock and stockholders’ equity
notes payable, shareholder
notes payable, mlsc, current																																			597,070	586,742
accrued interest
convertible promissory notes, net of debt discount
convertible promissory notes, related party
redeemable and convertible preferred stock:
series b-1 convertible preferred stock par value 0.0001...
series a-1 convertible preferred stock par value 0.0001...
total redeemable and convertible preferred stock
stockholders’ equity
total redeemable and convertible preferred stock and stockholders’ equity																																		12,445,778
total liabilities, redeemable and convertible preferred stock and stockholders’ equity																																		13,974,992	5,958,794	7,835,274
cash																																			4,958,088	7,110,241
liabilities, redeemable and convertible preferred stock and stockholders' equity
notes payable, shareholder, current
accrued interest, current																																			4,602	5,247
notes payable, shareholder, net of current portion																																			876,458	876,458
notes payable, mlsc, net of current portion																																			421,838	575,035
accrued interest, net of current portion																																			191,892	167,592
stockholders' equity
total stockholders' equity																																			2,575,385	3,922,558
total redeemable and convertible preferred stock and stockholders' equity																																			2,575,385	3,922

Cashflow Statements:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30

cash flows from operating activities
net loss	-3,009,399	-3,813,938	-3,662,916	-4,631,972	-3,465,058	-260,081	-966,409	-1,121,607	-3,835,632	-2,460,104	-2,029,016	-1,014,150	-2,644,295	-2,167,450	-2,829,716	-2,908,922	-2,814,934	-2,733,198	-2,057,022	-2,621,315	-2,960,794	-1,698,413	-2,776,571	-3,286,934	-3,801,993	-2,761,504	-2,788,118	-2,565,327	-2,598,060	-2,691,954	-2,649,822	-2,629,561	-2,345,402	-1,900,276	-1,258,949
adjustments to reconcile net loss to net cash from operations:
depreciation and amortization	291,590
stock-based compensation	597,248	564,959	583,990	394,889	540,204	321,858	324,185	-91,893	320,288	334,089	330,425	280,061	171,027	273,368	305,633	345,223	266,270	265,362	301,763	363,312	165,971	203,110	181,702	106,281	123,209	167,689	146,951	385,748	207,605	171,705	150,881	155,725	336,355	41,286	-57,196
accretion of discount on short-term investments	-41,594	-18,304	-1,325	-11,636	-11,747	-78	-9,521	-59,946	-49,053
credit losses		2,590	103,779	0	51,643	38,400	0
amortization of deferred offering costs	262,239		31,006
amortization of right-of-use assets	180,067	190,935	187,779	237,649	288,951	374,469	72,535	65,399	58,658	52,322	91,428	107,796	101,829	96,217	90,973	85,984	76,654	63,439	59,876	27,594	39,059
change in fair value of derivative liabilities	-839,064																					0	-888	-39,717	-82,101	-38,530	-14,535	-99,450	-41,970	-4,991	-13,310	-2,661	-15,307	-52,429	-219,374
other non-cash changes	27,600				-34,171
changes in operating assets and liabilities:
accounts receivable	-691,038	1,488,183	1,864,055	-2,338,218	-637,054	-443,252	-1,014,118	-820,910	718,676	129,997	-861,473	-104,656	340,533	-315,314	-239,274	329,285	272,748	235,707	-1,087,534	-364,097	169,642	-608,869	17,994	-33,069	101,000	-290,280	197,007	85,157	-33,912	-61,984	48,402	-233,506	145,594	-41,330	-1,678
inventories	-447,321	356,196	185,864	-653,968	-550,772	178,151	-757,138	-218,968	-597,087	-294,681	-159,007	226,055	-157,148	145,320	-256,191	-266,789	-229,740	-170,956	80,934	58,477	-86,677	52,689	-80,898	-73,510	-169,826	89,046	-107,211	-63,526	-131,871	10,515	-41,834	-45,575	-63,923	-89,202	4,748
prepaid expenses and other current assets	350,375	-344,142	-340,916	12,246	-628,186	-272,574	-251,576	-370,272	6,897	324,061	-227,146	-158,861	-53,577	-15,373	-105,420	487,710	-142,240	99,237	3,868	-234	-426,515		130,147	16,889	-117,016
other assets		-2	137,315	-60,591	-70,210	101,413	198,297			0				1	-1	375	-16,079					0	0	0	57,987	-85,265	-25,574
accounts payable and accrued expenses	1,207,038	-1,003,523	-1,368,155	-1,972,059	1,440,877	2,797,332	904,822	903,932	87,041	-351,845	1,253,384	501,714	386,880	-447,716	221,815	-780,825	294,828	535,997	559,312	-934,413	952,339	723,618	443,019	-923,699	974,991
operating lease liabilities	-124,570	-136,677	50,220	-23,869	164,405	-136,868	-129,310	-122,174	-115,191	-107,970	-120,353	-123,358	-109,109	-108,379	-103,136	-98,146	-97,098	-41,063	-106,445	33,943	21,040
deferred revenue	-30,724	83,472	25,970	-21,072	46,738	51,144	19,955	14,686	-11,181	-22,175	29,813	-187	-20,093	-2,587	20,594	0	1,650	0	0	0	-2,512	-4,172	-2,016	4,569	1,218	-29	3,867	-25,270	23,850	-74,056	-11,818	6,957	-24,423	143,090	-12,602
income taxes payable	70,217		136,963				25,902	98,830	77,405		-109,718	-4,643	39,417
net cash from operating activities	-2,197,336	-1,140,499	-1,828,780	-8,865,276	-2,676,899	3,365,728	-1,494,144	-1,915,924	-3,245,564	-2,355,745	-1,714,806	-285,523	-1,816,690	-2,464,221	-2,798,724	-2,647,997	-2,322,600	-1,828,533	-2,209,648	-3,396,806	-2,112,708	-1,154,080	-1,768,018	-3,665,773	-2,445,025	-2,644,115	-2,290,281	-2,287,539	-3,119,882	-2,513,011	-2,482,951	-2,344,988	-2,265,360	-1,430,415	-1,975,999
capital expenditures	-327,807	1,238,645	-1,052,856	-1,257,348	-670,688	-860,248	-320,704	-119,365	-59,808	-31,665	-54,093	-14,973	-45,085	-3,385	-5,736	-52,793	-49,879	-23,935	-54,883	-203,155	-44,489	-15,458	-22,416	0	-7,878	-13,730	-3,358	-29,499	-5,404	-9,497	-35,913	-16,533	-64,924	-59,758	-2,257
free cash flows	-2,525,143	98,146	-2,881,636	-10,122,624	-3,347,587	2,505,480	-1,814,848	-2,035,289	-3,305,372	-2,387,410	-1,768,899	-300,496	-1,861,775	-2,467,606	-2,804,460	-2,700,790	-2,372,479	-1,852,468	-2,264,531	-3,599,961	-2,157,197	-1,169,538	-1,790,434	-3,665,773	-2,452,903	-2,657,845	-2,293,639	-2,317,038	-3,125,286	-2,522,508	-2,518,864	-2,361,521	-2,330,284	-1,490,173	-1,978,256
cash flows from investing activities
purchases of equipment	-327,807	1,238,645	-1,052,856	-1,257,348	-670,688	-860,248	-320,704	-119,365	-59,808	-31,665	-54,093	-14,973	-45,085	-3,385	-5,736	-52,793	-49,879	-23,935	-54,883	-203,155	-44,489	-15,458	-22,416	0	-7,878	-13,730	-3,358	-29,499	-5,404	-9,497	-35,913	-16,533	-64,924	-59,758	-2,257
purchases of software development costs	-166,538
purchases of short-term investments		-4,242,001	0	0	-1,225,410	-492,810	0	0	-5,482,757	-673,883	-2,011,232
net cash from investing activities	-494,345	-4,594,220	189,698	-757,348	-1,896,098	-1,353,199	2,825,110	2,330,635	-3,542,565	2,294,452	-1,315,325	-2,963,607	-45,085	-3,385	-5,736	-52,793	-248,879	-23,935	-54,883	-203,155	-44,489	-15,458	-22,416	0	-7,878	-13,730	-3,358	-29,499	-5,404	-9,497	-35,913	-16,533	-64,924	-59,758	-2,257
cash flows from financing activities
deferred debt origination costs				0	-36,506
net cash from financing activities		7,513,885	-50,000	4,000,000	-36,506	15,770,020	-199,500	0	5,361,909	31	3,949,516	-8,147	5,772,057					4,779,590	1,098,593	1,208	7,288,275	18,923	4,374,990	672,710	11,713,953	2,794,945	-46,877	-247,650	5,818,051	-30,110	-71,453	-48,180	3,487,341	9,491,458	-173,897
effect of foreign exchange rate changes on cash	-43,920	-697	2,208	69,257	30,929	-32,851	20,109	-3,337	-10,360	20,821	-13,921	0	7,311	16,695	-11,434	-5,803	-10,392	-9,502	232	0	-1,122	-705	-394	0	-23
net change in cash and cash equivalents	-2,735,601
cash and cash equivalents beginning of year	14,707,027				24,747,373
cash, cash equivalents and restricted cash end of year	11,971,426				20,168,799
cash paid during the period for income taxes	19,200
cash paid during the period for interest	410,474																								203,552									18,062	19,501
non-cash financing and investing activities
unrealized loss from mark to market on short-term investments	-3,398	367
depreciation		263,263	246,851	190,798	158,442	91,564	48,683	35,978	29,685	27,890	35,794	51,990	48,632	49,057	49,097	49,015	45,630	50,757	36,909	35,016	23,313	25,653	26,708	26,633	26,388	24,446	25,602	23,449	21,627	20,849	19,933	14,301	14,599	4,430	2,439
amortization of final payment fees of old debt
amortization of deferred offering cost
income tax payable
tenant improvement allowance
purchases of software development
maturities of short-term investments		0	1,242,554			-141	3,145,814	2,450,000	2,000,000	3,000,000	750,000
proceeds from sale of pre-funded warrants, net of offering costs						0	0	0	763,138			0	2,064,012
proceeds from sale of common stock and pre-funded warrants, net of offering costs										0
repayment of debt																						0	0	0	-1,703,552
final payment fees of old debt
payment of debt issuance costs
proceeds from issuance of debt, revolving credit line		0
proceeds from issuance of debt, term loan		0
proceeds from issuance of debt, avenue capital
net increase in cash and cash equivalents				-5,553,367	-4,578,574			411,374	-1,436,580	-40,441	905,464
cash, cash equivalents and restricted cash beginning of year
supplemental disclosure of cash flow information
right of use assets obtained in exchange for lease obligations
inventory reserves
other non-cash charges			141,908				39,549	-19,299	63,930		-38,485	-59,798	49,012	11,984	30,250	75,885	-6,364	-20,392	-1,309	4,911	-3,139	-16,120	655	178	-3,159	-5,211	2,028
net proceeds from common stock offering							0	0	4,598,771			0	3,708,045
deferred offering costs
net increase in cash, cash equivalents and restricted cash															-2,815,894	-2,706,593	-2,581,871		-1,165,706	-3,598,753	5,129,956		2,584,162	-2,993,063	9,261,027			-2,564,688	2,692,765		-2,590,317	-2,409,701	1,157,057
cash, cash equivalents and restricted cash, beginning of period															0	0	15,524,378		0	0	12,241,261		0	0	4,540,455		0	0	6,615,794		0	0	13,011,373
cash, cash equivalents and restricted cash, end of period															-2,815,894	-2,706,593	12,942,507		-1,165,706	-3,598,753	17,371,217		2,584,162	-2,993,063	13,801,482		-2,340,516	-2,564,688	9,308,559		-2,590,317	-2,409,701	14,168,430
supplemental disclosure of non-cash investing and financing activities
net proceeds from issuance of debt
cash and cash equivalents, beginning of period								0	6,871,306		0
cash and cash equivalents, end of period								411,374	5,434,726		905,464
unrealized gain from mark to market on short-term investments
amortization of deferred debt origination cost					29,039
loss on equity investment										69,663	70,124	12,514	17,202	16,651	16,652
net settlement of vested restricted stock units to fund related employee statutory tax withholding										31	0											0	0			-1	-1,779	-235,059	156,517	-2,801	-3,222	-5,041	-63,149
deferred offering costs incurred in a prior period to additional paid in capital
right of use assets obtained in exchange for lease liabilities															0	0	225,665		0	0	654,091
deferred offering costs incurred in a prior period to additional paid-in capital											0	0	-91,952
bad debt expense										15,775	-374	0	13,000	0	0	0	26,075					-20,000	-16,000	21,839	24,000				16,275	32,550
investment in china joint venture
proceeds from issuances under equity line of credit, net of costs
cash and cash equivalents end of year
issuance of 50,000 shares of common stock as commitment fee for future financing														0
investment in jiangxi myomo medical assistive appliance co., ltd.
investment in jiangxi myomo medical assistive appliance co. ltd.															0	0	-199,000
net increase in cash, cash equivalents													3,917,593
cash, cash equivalents, beginning of period													5,345,967
cash, cash equivalents, end of period													9,263,560
loss on disposal of asset																		0	0	0	202	370	0			0	0	2,161	320
other liabilities																		-113,423	0	0	-4,637	-47,829	87,997
proceeds from issuances under equity line of credit net of costs
proceeds from exercise of warrants																		4,779,590	0	0	7,288,275	-1	1	0	161,298					0	0	5,901	3,550,490
proceeds from at the market offering, net of offering costs
proceeds from issuance under at-market sales facility, net of offering costs
proceeds from payment of grants																							0	0	6,928
property and equipment included in accounts payable and in accrued expenses and other liabilities																				-58,196	94,298
non-cash interest expense, debt discount																						0	12,135	40,025	166,643
amortization of original issue discount																						0	18,843	75,894	67,132
loss on extinguishment of debt																						12,786	189,155	348,079	159,202
payment of prepayment penalty on debt																						0	0	0	-255,533
proceeds from exercise of stock options																						0	0			-1	1			0	0			0	23,972
proceeds from payments under grants
supplemental disclosure of non-cash interest, investing, and financing activities
inventory capitalized as sales demo equipment																						0	0	0	2,743	0	0	15,607	2,108	0	19,036	6,298	27,844
sales demo equipment transferred to rental inventory																						0	0
deferred issuance costs to additional paid-in capital paid in prior period																						0	0	131,976	29,277
issuance of common stock for debt																						90,832	1,149,153
amortization of original issue discount and debt restructuring fee
proceeds from public offering, net of offering costs
supplemental disclosure cash flow information
proceeds from issuance under at-market sales facility
proceeds from public offering																								0	13,504,812		-45,099	0	5,648,928
inventory reserve																																	-645
prepaid expenses and other																										-33,474	30,746	-32,758	-128,256	25,590	-258,084	-89,689	15,182	77,604	-191,909
customer advance payments																									27,300	-63,527	63,527
proceeds from issuance of debt
net increase in cash, cash equivalents, and restricted cash
cash, cash equivalents, and restricted cash beginning of year
cash, cash equivalents, and restricted cash end of year
cumulative impact from the adoption of asc 606
issuance of selling agent warrants
put option bifurcated from term loan
accrued interest converted to principal
issuance of warrants recorded as a derivative liability																											0	0	196,236
payments of issuance costs																													12,606	-27,309	-68,231
net decrease in cash, cash equivalents, and restricted cash
excess and obsolete inventory reserve																															-2,242				-5,073
accounts payable and other accrued expenses																											175,429	66,449	-432,998	52,874	291,218	449,489	-327,390	147,003	-178,117
net decrease in cash, cash equivalents and restricted cash
other current liabilities																													-22,492
amortization of debt discount																																		0	0
debt discount on convertible notes																																		0	0
common stock issued for services and software license
accrued interest																																		144,220	23,656
proceeds from ipo, net of offering costs																																		0	4,368,310.577
proceeds from private placement, net of offering costs																																		0	0
proceeds from fpo, net of offering costs
proceeds from convertible promissory notes																																		0	0
repayment of note payable, mlsc																																		-1,018,908	-142,869
conversion of accrued interest to principal																																		0	0
exchange of 2015 convertible promissory notes for 2016 convertible promissory notes																																		0	0
accretion of convertible preferred stock to redemption value																																		0	0
conversion of convertible preferred stock into common stock																																		0	0
conversion of convertible promissory notes and accrued interest into common stock																																		0	0
issuance of selling agent warrants in connection with ipo																																		0	0
deferred offering costs to additional paid-in capital upon ipo closing																																		0	0
common stock issued for repayment of promissory notes and related accrued interest
common stock issued for services																																			0
ipo issuance costs included in accounts payable and accrued expense																																			23,070
ipo gross proceeds of 4,991,236 are reduced by 622,921 of ipo offering costs that were incurred in 2017. another 438,237 of ipo deferred offering costs were paid for in 2016.
ipo gross proceeds of 4,991,236 are reduced by 567,921 of ipo offering costs that were incurred in 2017. another 438,237 of ipo deferred offering costs were paid for in 2016.
proceeds from issuance of convertible promissory notes
supplemental disclosure of non-cash operating activities
restricted cash
net increase in cash																																			-2,152,153
cash, beginning of period																																			0
cash, end of period																																			-2,152,153
supplemental disclosure of non cash investing and financing activities

Myomo, Inc(NYSE MKT:MYO)

Myomo, Inc
(NYSE MKT:MYO)